NCT01544595 · Interventional trial
Extension Study of Secukinumab Prefilled Syringes in Subjects With Moderate to Severe Chronic Plaque-type Psoriasis Completing Preceding Psoriasis Phase III Studies With Secukinumab
Overall registry status Completed
Phase 3
Conditions Moderate to Severe Plaque-type Psoriasis
Delaware Valley sites
- Novartis Investigative Site · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory